Intuitive Surgical, Inc.
Every calculator, already run for ISRG
Open the full toolkit →You have the numbers on ISRG. Get the argument.
A written report on which of these readings actually decide the outcome for Intuitive Surgical, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
33 analysts covering ISRGAnalyst Price Target Disagreement for Intuitive Surgical, Inc.
Wall Street's bull case implies +81% from the current price; the bear case implies -14%. A 95% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; in…
ISRG — frequently asked
Is ISRG a buy right now?
Wall Street's consensus rating on Intuitive Surgical, Inc. is Buy across 33 analysts, with a mean price target of $477.25 (+26% vs. the current $378.81). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is ISRG overvalued?
ISRG trades at 43.5x trailing earnings, against a DCF fair value of $105 per share. The current price implies 24% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is ISRG's next earnings date?
Intuitive Surgical, Inc. is next scheduled to report earnings around Oct 20, 2026. A full ISRG research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Intuitive Surgical, Inc.?
Analysts covering Intuitive Surgical, Inc. (ISRG) range from a bear-case target of $324.00 to a bull-case high of $685.00, with a mean consensus target of $477.25 across 29 analysts. The spread of $361.00 (95% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Intuitive Surgical, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Intuitive Surgical, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full ISRG research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Intuitive Surgical, Inc., in minutes. 3 free reports included with every account — no credit card required.